| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |